April 29 - 30, 2019

ACI’s 13th Annual PIV Disputes Conference

This event has already occurred.
The Conrad
New York, NY

Venable is sponsoring ACI's 13th Annual Paragraph IV Disputes, being held at The Conrad in New York on April 29-30. Venable partner Christina Schwarz will be speaking on a panel, "The Present State of Paragraph IV Litigation and Its Impact on the Pharmaceutical Industry: Legal Analyses and Business Prognoses." The panel will cover the following topics: 

  • Investigating the most popular districts, filing trends, settlements, and timings
  • Examining how judicial shortages in key districts are impacting ANDA litigation and venue selection
  • Understanding how this is influencing PTAB filings
  • Analyzing the connection between recent Paragraph IV filings and the speed of ANDA approvals
  • Studying IPR outcomes of Orange Book patents and appreciating the correlation with District Court litigation
  • Exploring when settlement is considered as a favorable outcome in an IPR and its consequences for related District Court litigation
  • Understanding how ANDA litigation outcomes affect business forecasts in this next era of the patent cliff
  • Appreciating how Paragraph IV outcomes impact business decisions, including R&D, licensing, M&A activity, and beyond

Venable partner Daniel Minion will be speaking on a panel, "The Evolving Induced Infringement Analysis."  This panel will cover the following topics:

  • Examining precedent where courts have found inducement to exist when there is an element of inevitability resulting in infringement
  • Surveying decisions on infringement based on drug labels for support of execution of the infringing acts
  • Identifying strategic considerations of labeling language based on this new jurisprudence